Peptide and Heparin Market: Vendors of Peptide Therapeutics are Outsourcing Manufacturing Processes to Developing Countries
According to Fact.MR, the global peptide and heparin market is projected to reflect a high single-digit CAGR throughout the forecast period (2017-2026). The market is estimated to reach nearly US$ 35,000 Mn revenues by 2026-end. A major component in the innate immune system, host defense peptides play an instrumental role in the defense against surmounting microbes. Such peptides have been providing not only direct broad-spectrum antimicrobial effects, but also an array of additional functionalities, encompassing immune modulating and anti-inflammatory effects along with effects on chemotaxis and angiogenesis. Meanwhile, heparin has becoming popular as an anti-inflammatory and antitumor agent, substantiated by new research finding among healthcare professionals. The quashing of bovine heparin by the FDA was majorly attributed to the concern with respect to adulteration. Having said that, on the back of acute shortage of procine heparin, FDA has started to encourage bo...